Skip to main content

Advertisement

Table 1 Baseline characteristics of patients with hyperferritinemia and secondary HLH/sepsis/MODS/MAS

From: Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?

Variable Patients with secondary HLH/MAS (n= 23)
  Mean ± SD Median Range
Age, years 7.2 ± 3.6 6.7 2-15
PRISM III-24 score 23.9 ± 12.5 19.5 7-48
PELOD score 26 ± 13.8 24 4-53
Number of dysfunctional organs 4.6 ± 1 5 3-6
  Percentage Number  
Males/Females 74/26 17/6  
Artificial ventilation 87 20  
Underlying disease 78 18  
  1. HLH, hemophagocytic lymphohistiocytosis; MAS, macrophage activation syndrome; MODS, multiple organ dysfunction syndrome; PELOD, Pediatric Logistic Organ Dysfunction; PRISM, Pediatric Risk of Mortality; SD, standard deviation.